Outset Medical, Inc. (OM) vs Sera Prognostics, Inc. (SERA)

Outset Medical, Inc. and Sera Prognostics, Inc. are both Medical Devices companies. Outset Medical, Inc. and Sera Prognostics, Inc. are of similar size ($80.1M and $76.6M). Outset Medical, Inc. grew revenue faster over the last twelve months: −1.26% against −35.2%. Outset Medical, Inc. has the higher net margin (−63.1% vs −47,475.7%) and the higher return on invested capital (−86.1% vs −180.2%). Across the 18 metrics below, Outset Medical, Inc. leads on 12 and Sera Prognostics, Inc. on 6.

Valuation

Metric OM SERA Medical Devices median
P/E n/m n/m 23.22
P/S 0.62 1,485.46 2.34
P/B 0.76 1.75 2.33
Price to free cash flow n/m n/m 23.72
EV/EBITDA n/m n/m 11.54
EV/Sales 0.22 821.99 2.24
Earnings yield (103.81%) (32.52%) (10.09%)
Free cash flow yield (53.00%) (27.44%) (8.47%)

Profitability

Metric OM SERA Medical Devices median
Gross margin 41.76% (150.00%) 56.01%
Operating margin (56.06%) (53,282.86%) (15.03%)
Net margin (63.06%) (47,475.71%) (20.40%)
Free cash flow margin (33.00%) (40,760.00%) (7.24%)
Return on equity (60.09%) (45.03%) (15.32%)
Return on assets (27.97%) (33.47%) (19.72%)
Return on invested capital (86.10%) (180.22%) (10.33%)

Growth

Metric OM SERA Medical Devices median
Revenue growth (TTM) (1.26%) (35.19%) 8.80%
EPS growth (last fiscal year) 85.44% 32.32% 29.03%
Revenue growth, 5-year CAGR 19.06% 26.51% 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric OM SERA Medical Devices median
Debt to equity 1.03 0.00 0.07
Current ratio 5.19 1.98 2.50
Net debt to EBITDA 1.13 1.10 0.49

Dividend

Metric OM SERA Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric OM SERA Medical Devices median
Market cap 76.61m 80.08m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack